ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · DBD

Atlas market file · Equity · United States

DIEBOLD NIXDORF, IncDBD

Last close
75.38
Change
+1.10%
96-bar range
67.71 – 92.085
As of
7 Aug 2026

DIEBOLD NIXDORF, Inc is a calculating & accounting machines (no electronic computers) issuer listed as DBD on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:DBD

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

92.816286.356979.897573.438166.978723 Mar01 Jun07 Aug

up candle   down candle

Latest close75.38
Day change+1.10%
Window high92.085
Window low67.71
96-bar change-0.25%
SnapshotDaily · 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 104 weekly closes (+89.97% over the window).

91.377636.092419 Aug07 Aug

Source rail: Yahoo Finance chart API (DBD). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for DBD. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

DBD public profile

Company

Calculating & accounting machines (no electronic computers) issuer. DIEBOLD NIXDORF, Inc is connected to current market context, cited company sources and its retained research file.

Market

DIEBOLD NIXDORF, Inc trades as DBD on NYSE. DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files DBD under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Diebold Nixdorf's latest 10-Q shows it banked $891.8 million in revenue for the quarter ending March 2026, a figure that sounds less like a company thriving and more like a vending machine stuffed with dollar bills and coughing up the change. The business still manages to lose money on paper, with net income of just $5 million, which means the whole operation is running on fumes and executive PowerPoints. The balance sheet looks healthier, with $358.6 million in cash and $1.02 billion in equity, but the inventory pile has swollen to $553.1 million-enough to stock a small retail apocalypse or at least a slow quarter. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for DIEBOLD NIXDORF, Inc today

Open full report
DBD daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Diebold Nixdorf reported $891.8 million in revenue for the quarter ending 31 March 2026, but the headline masks a thin operating profit of $32.7 million and net income of just $5 million. The company’s cash position stands at $358.6 million, while its inventory has ballooned to $553.1 million-an increase of $38.7 million in a single quarter. Earnings per diluted share came in at $0.14 on 35.7 million shares outstanding. What looks like a cash-rich balance sheet is offset by a balance sheet that smells suspiciously like unsold terminals and overstocked branches.

What Diebold Nixdorf actually does is sell and service self-service technology: ATMs, kiosks, retail checkouts, and reverse vending machines, all wrapped in a support promise that sounds slicker than the reality. Its ‘eServices Portal’ and ‘Global Customer Experience Centers’ are meant to project a future where machines hum along, customers smile, and engineers sip espresso while debugging firmware. The evidence shows a different scene: a $22.1 million R&D budget, a services desk that logs real-world failures, and a product lineup that still relies on foot traffic in malls, banks, and supermarkets-venues that are not exactly booming. The company’s narrative is ‘omnichannel transformation’, but the filings read like ‘omni-channel inventory accumulation’.

The latest 10-Q gives us the numbers, the 13D/A gives us the management desks drama, and the product pages give us the polished brochure. The revenue number is real; the net income is real; the inventory build is real; the board’s interest is real. The gap between the platform story and the balance sheet is the only thing here that’s truly outsized. Revenue: $891.8M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). Net income: $5.0M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). Inventory net: $553.1M, up $38.7M (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html). EPS diluted: $0.14 (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/28823/000095012326004599/xslF345X06/form10q.html).

The company’s investor-relations page points to ‘News & Events’ and ‘Customer Experience Centers’ as proof of momentum, but the actual evidence trail is thinner than a printed receipt. The centres are real places you can visit, and the newsroom is real, but neither changes the fact that the latest hard numbers are the 10-Q. The portal pages for ‘eServices Portal Remote’ and the ‘Services Support Desk’ describe what the product is supposed to do; they do not supply revenue, profit, or order intake. The SEC filings are the only source that supplies audited figures, and they show a business that is profitable on paper but still lugging around an inventory load that smells like the last decade’s orders.

The website’s visual rail includes a glossy shot of a bright, futuristic Customer Experience Center, but the balance sheet is stuck in the present: $2.80 billion in liabilities against $1.02 billion in equity. The cash flow from operations is $31.7 million, which is enough to keep the lights on but not enough to fund a moonshot. The board’s 13D/A filing on 26 June 2026 suggests a push for change, yet the operating metrics remain stubbornly middle-aged. The gap between the marketing video and the 10-Q is not a bug; it is the company’s current business model.

The evidence does not show a breakout product launch, a regulatory tailwind, or a surge in orders. What it does show is a company selling hardware into sectors-banking, retail, recycling-that are structurally challenged by e-commerce, cashless trends, and rising interest costs. The ‘eServices Portal’ may be a genuine software offering, but the $22.1 million R&D line does not scream ‘disruptor’; it screams ‘defensive maintenance’. The ‘Global Customer Experience Centers’ are real, but they are not a substitute for audited revenue growth.

If Diebold Nixdorf’s next quarter brings a clear uptick in orders, a reduction in inventory, or a credible path to net profitability above $10 million, the file will change. Until then, the balance sheet remains the single source of truth, and it is telling a story that the brochures have not yet caught up with.

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
DBD
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

DBD technical readout

Trend strength (ADX 14)
21.3
Average true range (ATR 14)
2.854
ATR as % of price
3.15%
Volatility compression (ATR14/ATR50)
1.02x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

DBD evidence rails

Atlas uses the specific public rails available for DBD: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on DBD

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for DBD Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep DBD research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

DBD FAQ

What is DIEBOLD NIXDORF, Inc (DBD)?DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...

DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for DBD?DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...

DIEBOLD NIXDORF, Inc (DBD) has a latest verified close of 75.38, up 1.10%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files DBD under USA Stocks for browsing.

How often is the DBD page updated?The DBD public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The DBD public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for DBD?The DBD file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DBD. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The DBD file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DBD. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on DBD?Yes. The workstation can open DBD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open DBD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this DBD page investment advice?No. The DBD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The DBD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →